Ambient scribe
Abridge
Abridge is clinician-controlled documentation and decision support. UChicago Medicine documents patient refusal and note-correction routes, but these local commitments cannot describe every customer. Platform expansion does not establish that all patient recordings feed every offering.
Published September 8, 2026 as an AI-assisted draft. The public report separates documented facts, agency judgments and unresolved questions.
Summary judgment · 43 out of 100 toward patient-directed
Enterprise documentation and clinical decision support. UChicago Medicine is one documented deployment example, not evidence of uniform practice across all customers.
Mixed
Abridge is clinician-controlled documentation and decision support. UChicago Medicine documents patient refusal and note-correction routes, but these local commitments cannot describe every customer. Platform expansion does not establish that all patient recordings feed every offering.
Patient agency
How this tool changes agency
Open notes can support patient checking. Clinician-facing citations do not establish patient access to the same reasoning, recordings or source interface.
Actual consent practice and downstream use across customers, and current litigation status, were not established
Patient agency assessment
Who sets and changes the goal?
Clinical users decide what enters the record and what action follows. UChicago documents a real patient refusal and correction route, with no claim that the patient controls the assistant itself.
What can the patient understand, question, or do?
Open notes can support patient checking. Clinician-facing citations do not establish patient access to the same reasoning, recordings or source interface.
Can the patient evaluate the conditions of use?
Consent and retention must be described by deployment. Vendor expansion into payer and life-sciences workflows does not prove that the same patient audio feeds every offering.
Text findings
Conditions of use
Published controls and their limits
Consent and retention must be described by deployment. Vendor expansion into payer and life-sciences workflows does not prove that the same patient audio feeds every offering.
What remains unknown?
Not tested or not established
Actual consent practice and downstream use across customers, and current litigation status, were not established
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
- https://www.uchicagomedicine.org/forefront/patient-care/ai-ambient-clinical-documentation-what-to-know
- https://www.abridge.com/cds
Source-specific findings and retrieval limitations are recorded in the full report.
Review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Actual consent practice and downstream use across customers, and current litigation status, were not established No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
AI-assisted draft · Moderate for public deployment policy and CDS design (AI-assisted draft)